- Report
- June 2023
- 95 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- May 2023
- 108 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- February 2022
- 85 Pages
Global
From €3200EUR$3,767USD£2,839GBP
- Report
- February 2024
- 98 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- June 2023
- 85 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- July 2024
- 280 Pages
Global
From €2416EUR$2,655USD£2,071GBP
The Vitreoretinal Surgery market is a subset of the Optical market, focusing on the diagnosis and treatment of diseases of the vitreous and retina. This includes procedures such as vitrectomy, laser photocoagulation, and scleral buckling. Vitreoretinal Surgery is a highly specialized field, requiring specialized equipment and expertise.
The market is driven by the increasing prevalence of retinal diseases, such as age-related macular degeneration, diabetic retinopathy, and retinal detachment. Advances in technology have also enabled more precise and less invasive treatments, leading to improved outcomes and increased demand for Vitreoretinal Surgery.
Some companies in the Vitreoretinal Surgery market include Alcon, Bausch + Lomb, Carl Zeiss Meditec, Ellex, and Topcon. Show Less Read more